Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 613 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
8 Oct 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$704.28K
6.1%
1 Oct 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.64M
14.8%
15 Sep 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.94M
14.8%
10 Sep 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.35M
16.4%
10 Sep 2021
CVP, TAVR
Sold, plan not stated
7,830
$959.88K
2.1%
8 Sep 2021
CVP, Critical Care
Sold, plan not stated
9,741
$1.18M
26.2%
8 Sep 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$769.95K
6.1%
10 Aug 2021
CVP, TAVR
Sold, plan not stated
7,830
$893.68K
2.1%
9 Aug 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$733.68K
6.1%
6 Aug 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.26M
16.4%
3 Aug 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.72M
14.8%
2 Aug 2021
CVP, Critical Care
Sold, plan not stated
15,000
$1.70M
35.1%
12 Jul 2021
CVP, TAVR
Sold, plan not stated
7,830
$841.57K
2.1%
9 Jul 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.20M
16.4%
8 Jul 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$677.67K
6.1%
1 Jul 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.40M
14.8%
15 Jun 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$641.37K
6.1%
15 Jun 2021
CVP, Critical Care
Sold, plan not stated
3,410
$344.99K
11.0%
14 Jun 2021
CVP, Surgical Structural Heart
Sold, plan not stated
24,000
$2.40M
60.3%
14 Jun 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.10M
16.4%
14 Jun 2021
CVP, TAVR
Sold, plan not stated
7,830
$782.30K
2.1%
9 Jun 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.16M
14.8%
28 May 2021
CVP, Critical Care
Sold, plan not stated
2,061
$196.39K
6.9%
25 May 2021
CVP, Critical Care
Sold, plan not stated
4,665
$448.30K
13.6%
24 May 2021
Chairman & CEO
Sold, plan not stated
33,000
$3.16M
14.9%
10 May 2021
CVP, TAVR
Sold, plan not stated
7,830
$722.08K
2.1%
7 May 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.02M
17.3%
7 May 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$583.37K
6.2%
7 May 2021
CVP, Critical Care
Sold, plan not stated
3,389
$311.35K
9.9%
5 May 2021
Chairman & CEO
Sold, plan not stated
35,550
$3.28M
26.8%
23 Apr 2021
VP, Corporate Controller indirect
Sold, plan not stated
12,000
$1.17M
37.0%
23 Apr 2021
Director
Sold, plan not stated
6,707
$654.07K
22.9%
22 Apr 2021
CVP, Critical Care
Sold, plan not stated
3,389
$319.92K
11.2%
12 Apr 2021
CVP, TAVR
Sold, plan not stated
7,830
$672.11K
2.1%
9 Apr 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.10M
21.1%
8 Apr 2021
Chairman & CEO
Sold, plan not stated
68,550
$5.79M
24.5%
8 Apr 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$538.99K
6.4%
1 Apr 2021
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
13,020
$1.09M
8.5%
15 Mar 2021
CVP, Critical Care
Sold, plan not stated
3,389
$276.75K
11.2%
12 Mar 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.08M
21.2%
9 Mar 2021
Chairman & CEO
Sold, plan not stated
68,550
$5.67M
24.5%
8 Mar 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$516.70K
6.4%
1 Mar 2021
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
13,020
$1.10M
8.6%
1 Mar 2021
CVP, TAVR
Sold, plan not stated
7,830
$657.64K
2.1%
23 Feb 2021
Chairman & CEO
Sold, plan not stated
68,550
$5.77M
22.1%
16 Feb 2021
CVP, Critical Care
Sold, plan not stated
3,389
$298.91K
11.2%
11 Feb 2021
CVP, Japan & Intercontinental
Sold, plan not stated
11,745
$1.02M
11.2%
5 Feb 2021
CVP,Strategy/Corp Development
Sold, plan not stated
13,077
$1.12M
21.2%
4 Feb 2021
Director
Sold, plan not stated
8,200
$698.75K
12.1%
1 Feb 2021
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
20,523
$1.71M
12.8%
Showing 251–300 of 613. ← Newer Page 6 of 13 Older →